Results 81 to 90 of about 1,841,724 (311)

Number of injuries within each injury category.

open access: yes, 2013
Within each Treatment bin is a representation of the number of injuries for each injury category of Mortal, Moderate, and Mild. The y-axis is number of injuries, x-axis is each Treatment (exposure and control: ex., T1 =  Treatment 1 Exposure; T1 Ctrl  = 
Christa M. Woodley (318747)   +4 more
core   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Completeness of †-categories and the complex numbers [PDF]

open access: yesJournal of Mathematical Physics, 2011
The complex numbers are an important part of quantum theory, but are difficult to motivate from a theoretical perspective. We describe a simple formal framework for theories of physics, and show that if a theory of physics presented in this manner satisfies certain completeness properties, then it necessarily includes the complex numbers as a ...
openaire   +1 more source

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi   +9 more
wiley   +1 more source

Number of statements per category achieving consensus.

open access: yes
Number of statements per category achieving consensus.
Rosalind Herman (8945618)   +3 more
core   +1 more source

The total number of segments in each SWE distribution category.

open access: yes, 2023
The total number of segments in each SWE distribution category.
Tomohiro Kuwae (343790)   +3 more
core   +1 more source

Effectiveness of a Novel Low‐Density Lipoprotein Apheresis Device Rheocarna in Patients Undergoing Hemodialysis With Chronic Limb‐Threatening Ischemia: A Single‐Center Retrospective Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic limb‐threatening ischemia (CLTI) is a severe form of lower‐extremity artery disease characterized by distal lesions and microcirculatory impairment, limiting revascularization efficacy. Rheocarna is a direct hemoperfusion low‐density lipoprotein (LDL) adsorption device with potential rheological and anti‐inflammatory ...
Kunihiro Ishioka   +12 more
wiley   +1 more source

Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Patients requiring long‐term continuous renal replacement therapy (CRRT) generally have poor prognoses. This study evaluated whether adding continuous intravenous sodium infusion (cIVNa) is associated with improved hemodynamics and outcomes in patients undergoing long‐term CRRT for ≥ 7 days.
Akinori Yamaguchi   +6 more
wiley   +1 more source

The functor category of a finitely accessible additive category

open access: yes, 2012
In this note, we prove that if A is a finitely accessible additive category, then for every object A ? A, there exists a pure monomorphism from A to a quasi-product of indecomposable pure injective objects in A.
Berktaş, Mustafa Kemal   +1 more
core  

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Home - About - Disclaimer - Privacy